持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/26 | 3,440 | 3,445 | 3,410 | 3,410 | -15 | -0.4% | 26,900 |
| 2022/08/25 | 3,410 | 3,455 | 3,405 | 3,425 | +15 | +0.4% | 30,800 |
| 2022/08/24 | 3,410 | 3,415 | 3,375 | 3,410 | -10 | -0.3% | 40,600 |
| 2022/08/23 | 3,415 | 3,435 | 3,385 | 3,420 | -25 | -0.7% | 36,500 |
| 2022/08/22 | 3,380 | 3,455 | 3,345 | 3,445 | +40 | +1.2% | 38,200 |
| 2022/08/19 | 3,450 | 3,450 | 3,380 | 3,405 | -5 | -0.1% | 29,400 |
| 2022/08/18 | 3,475 | 3,475 | 3,395 | 3,410 | -75 | -2.2% | 36,000 |
| 2022/08/17 | 3,445 | 3,500 | 3,445 | 3,485 | +90 | +2.7% | 64,700 |
| 2022/08/16 | 3,455 | 3,455 | 3,385 | 3,395 | -60 | -1.7% | 24,300 |
| 2022/08/15 | 3,445 | 3,460 | 3,415 | 3,455 | +25 | +0.7% | 26,000 |
| 2022/08/12 | 3,395 | 3,450 | 3,370 | 3,430 | +40 | +1.2% | 43,300 |
| 2022/08/10 | 3,360 | 3,405 | 3,350 | 3,390 | +30 | +0.9% | 25,100 |
| 2022/08/09 | 3,405 | 3,430 | 3,360 | 3,360 | -45 | -1.3% | 25,600 |
| 2022/08/08 | 3,420 | 3,425 | 3,365 | 3,405 | -20 | -0.6% | 29,300 |
| 2022/08/05 | 3,370 | 3,425 | 3,370 | 3,425 | +35 | +1% | 40,400 |
| 2022/08/04 | 3,405 | 3,430 | 3,365 | 3,390 | -15 | -0.4% | 41,400 |
| 2022/08/03 | 3,475 | 3,515 | 3,385 | 3,405 | -55 | -1.6% | 73,000 |
| 2022/08/02 | 3,410 | 3,500 | 3,400 | 3,460 | +60 | +1.8% | 111,500 |
| 2022/08/01 | 3,265 | 3,505 | 3,225 | 3,400 | +140 | +4.3% | 128,900 |
| 2022/07/29 | 3,360 | 3,360 | 3,250 | 3,260 | -90 | -2.7% | 40,500 |
| 2022/07/28 | 3,360 | 3,370 | 3,305 | 3,350 | -10 | -0.3% | 36,200 |
| 2022/07/27 | 3,355 | 3,375 | 3,330 | 3,360 | +5 | +0.1% | 26,000 |
| 2022/07/26 | 3,375 | 3,390 | 3,335 | 3,355 | +5 | +0.1% | 29,500 |
| 2022/07/25 | 3,345 | 3,375 | 3,345 | 3,350 | -35 | -1% | 20,400 |
| 2022/07/22 | 3,380 | 3,415 | 3,380 | 3,385 | +5 | +0.1% | 31,700 |
| 2022/07/21 | 3,335 | 3,390 | 3,310 | 3,380 | +20 | +0.6% | 24,600 |
| 2022/07/20 | 3,325 | 3,370 | 3,290 | 3,360 | +90 | +2.8% | 48,300 |
| 2022/07/19 | 3,305 | 3,305 | 3,245 | 3,270 | -35 | -1.1% | 19,200 |
| 2022/07/15 | 3,360 | 3,360 | 3,285 | 3,305 | -45 | -1.3% | 33,000 |
| 2022/07/14 | 3,330 | 3,350 | 3,320 | 3,350 | ±0 | ±0% | 16,800 |
| 2022/07/13 | 3,355 | 3,365 | 3,330 | 3,350 | +10 | +0.3% | 19,400 |
| 2022/07/12 | 3,385 | 3,400 | 3,320 | 3,340 | -60 | -1.8% | 33,100 |
| 2022/07/11 | 3,370 | 3,425 | 3,370 | 3,400 | +65 | +1.9% | 35,700 |
| 2022/07/08 | 3,355 | 3,385 | 3,295 | 3,335 | -20 | -0.6% | 59,100 |
| 2022/07/07 | 3,340 | 3,370 | 3,320 | 3,355 | +55 | +1.7% | 43,500 |
| 2022/07/06 | 3,280 | 3,315 | 3,275 | 3,300 | +20 | +0.6% | 36,100 |
| 2022/07/05 | 3,290 | 3,300 | 3,260 | 3,280 | ±0 | ±0% | 35,300 |
| 2022/07/04 | 3,300 | 3,325 | 3,275 | 3,280 | +30 | +0.9% | 33,500 |
| 2022/07/01 | 3,265 | 3,300 | 3,225 | 3,250 | -15 | -0.5% | 36,200 |
| 2022/06/30 | 3,285 | 3,335 | 3,250 | 3,265 | -15 | -0.5% | 53,800 |
| 2022/06/29 | 3,250 | 3,290 | 3,230 | 3,280 | +5 | +0.2% | 74,200 |
| 2022/06/28 | 3,200 | 3,280 | 3,190 | 3,275 | +45 | +1.4% | 49,300 |
| 2022/06/27 | 3,265 | 3,265 | 3,175 | 3,230 | ±0 | ±0% | 43,600 |
| 2022/06/24 | 3,215 | 3,235 | 3,180 | 3,230 | +30 | +0.9% | 31,200 |
| 2022/06/23 | 3,180 | 3,210 | 3,170 | 3,200 | +30 | +0.9% | 31,100 |
| 2022/06/22 | 3,175 | 3,185 | 3,155 | 3,170 | +35 | +1.1% | 38,000 |
| 2022/06/21 | 3,165 | 3,180 | 3,110 | 3,135 | +5 | +0.2% | 48,200 |
| 2022/06/20 | 3,145 | 3,170 | 3,130 | 3,130 | -5 | -0.2% | 50,200 |
| 2022/06/17 | 3,060 | 3,145 | 3,060 | 3,135 | +20 | +0.6% | 84,200 |
| 2022/06/16 | 3,110 | 3,145 | 3,095 | 3,115 | +50 | +1.6% | 42,900 |
551～
600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
